Your browser doesn't support javascript.
loading
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.
Juhnke, B-Ole; Gessi, Marco; Gerber, Nicolas U; Friedrich, Carsten; Mynarek, Martin; von Bueren, André O; Haberler, Christine; Schüller, Ulrich; Kortmann, Rolf-Dieter; Timmermann, Beate; Bison, Brigitte; Warmuth-Metz, Monika; Kwiecien, Robert; Pfister, Stefan M; Spix, Claudia; Pietsch, Torsten; Kool, Marcel; Rutkowski, Stefan; von Hoff, Katja.
Afiliación
  • Juhnke BO; HIT-MED Study Centre, Clinic for Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Gessi M; Neuropathology Unit, Division of Pathology, Fondazione Policlinico Universitario "A Gemelli" IRCCS, Catholic University Rome, Rome, Italy.
  • Gerber NU; Department of Oncology, University Children's Hospital Zürich, Zürich, Switzerland.
  • Friedrich C; Department of Paediatrics and Paediatric Haematology/Oncology, University Children's Hospital, Klinikum Oldenburg AöR, Oldenburg, Germany.
  • Mynarek M; HIT-MED Study Centre, Clinic for Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • von Bueren AO; Department of Paediatrics, Obstetrics and Gynaecology, Division of Paediatric Haematology and Oncology, University Hospital of Geneva, Geneva, Switzerland.
  • Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Schüller U; Institute of Neuropathology, University Medical Centre Hamburg-Eppendorf and Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Kortmann RD; HIT Radiotherapy Reference Centre, Clinic for Radiotherapy, Leipzig University Medicine, Leipzig, Germany.
  • Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ) and German Cancer Consortium (DKTK), Essen, Germany.
  • Bison B; Institute for Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Augsburg, Germany.
  • Warmuth-Metz M; HIT Neuroradiology Reference Centre, Institute for Diagnostic and Interventional Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
  • Kwiecien R; HIT Neuroradiology Reference Centre, Institute for Diagnostic and Interventional Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
  • Pfister SM; Institute of Biostatistics and Clinical Research, Faculty of Medicine, University of Münster, Münster, Germany.
  • Spix C; Hopp Children's Cancer Center (KITZ), Heidelberg, Germany.
  • Pietsch T; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kool M; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Rutkowski S; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • von Hoff K; DGNN Brain Tumour Reference Centre, Institute of Neuropathology, University Hospital Bonn, Bonn, Germany.
Neuro Oncol ; 24(1): 127-137, 2022 01 05.
Article en En | MEDLINE | ID: mdl-33908610

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de Células Germinales y Embrionarias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de Células Germinales y Embrionarias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2022 Tipo del documento: Article